Life Sciences Tools and Services
Company Overview of Hovione FarmaCiencia SA
Hovione FarmaCiencia SA, a contract formulation and manufacturing company, develops and manufactures active pharmaceutical ingredients (APIs), IMPs, and MPs for the pharmaceutical industry. It offers contract manufacturing services that include development and manufacture of drug substance; development and manufacturing services for particle engineering; development and manufacture of drugs; DPI formulation development; inhalation development services; and DPI devices. The company also provides API products, such as corticosteroids, tetracycline antibiotics, anticholinergics, contrast agents, and LABA products for various diseases that include asthma, COPD, acne, allergic rhinitis, and other...
Founded in 1959
Key Executives for Hovione FarmaCiencia SA
Chief Executive Officer and Director
Chief Financial Officer and Vice President of Finance
Vice President of Sales & Business Development and President of Us Operations
Head of Particle Design Sciences In New Jersey
Director of Corporate Communications
Compensation as of Fiscal Year 2015.
Hovione FarmaCiencia SA Key Developments
Hovione Announces Executive Changes
Oct 12 15
Hovione announced the appointment of Ms. Kristine Senft as Vice President Sales and Marketing. Ms. Senft joined Hovione on the October 1, 2015 and will succeed Mr. Dave Hoffman Vice President Sales and Business Development when he retires in April 2016. Ms. Senft was most recently with DSM and brings a vast experience in Sales and Marketing. Based in East Windsor, New Jersey, Ms. Senft will report to Guy Villax, Hovione's Chief Executive Officer. Before joining Hovione, Ms. Senft previously served various roles as a Business Unit Director, DSM Biomedical and before that as SVP, Marketing and Sales, DSM Pharmaceutical Chemicals where she led both regional and global marketing and sales organizations while experiencing expatriate life in Vienna, Austria, working with many of the top global pharma and biopharma companies. She also worked for Albemarle Corporation for many years in mainly Sales and Business Management roles in their Fine Chemicals and Pharmaceutical API businesses.
Hovione Announces the Expansion of its New Jersey Facility
Sep 29 15
Hovione announced the expansion of its New Jersey facility in East Windsor, USA. This investment is part of the company's strategy to increase its global development and commercial capacity to meet the increasing demands of Hovione's customers. The expansion will add an additional 30,600 ft² (2,843 m²) to the 24,000ft² (2,211m²) facility. It will introduce a new commercial spray dryer unit to complement their existing pilot unit and this installation will be specifically designed to handle potent drug substances (APIs). In addition the expansion will more than double the drug substance capacity at the site to support the needs of the current and future customer base. The expansion is expected to add approximately 60 new jobs to the current workforce. The official ground breaking should occur in the first quarter of 2016 and the doubling of capacity is expected to be fully operational in early 2017.
Hovione FarmaCiencia SA Presents at BIO-Europe 2015, Nov-03-2015 04:00 PM
Sep 21 15
Hovione FarmaCiencia SA Presents at BIO-Europe 2015, Nov-03-2015 04:00 PM. Venue: Munich, Germany.
Similar Private Companies By Industry
Recent Private Companies Transactions